Immunoselective algorithm to devise multi-epitope subunit vaccine fighting against human cytomegalovirus infection

Area of Science:

• Vaccinology
• Immunoinformatics
• Computational Biology

Background:

• Human Cytomegalovirus (HCMV) causes asymptomatic infections but can lead to severe complications in immunocompromised individuals and is linked to cancers.
• Effective treatments or vaccines against HCMV are currently lacking, highlighting an urgent need for novel therapeutic strategies.
• HCMV infection poses significant health risks, necessitating the development of preventative measures.

Purpose of the Study:

• To design a subunit vaccine candidate for Human Cytomegalovirus (HCMV) using a combinatorial screening approach.
• To evaluate the immunogenic, safety, and binding properties of the designed vaccine.
• To computationally assess the vaccine's potential to elicit a protective immune response.

Main Methods:

• A subunit vaccine was designed incorporating B-cell, CTL, and HTL epitopes with a TLR-4 agonist adjuvant.
• Epitope conservancy, physicochemical properties, antigenicity, and allergenicity were analyzed.
• 3D structure determination, molecular docking, and molecular dynamics simulations were performed to assess binding and stability with TLR-4.

Main Results:

• A 964-amino acid subunit vaccine candidate exhibiting good immunogenicity and non-allergenicity was developed.
• The vaccine contains HTL epitopes capable of inducing IFN-γ release and conserved CTL/HTL epitopes across HCMV strains.
• Molecular docking and dynamics simulations confirmed strong binding affinity and complex stability with the TLR-4 receptor.

Conclusions:

• The designed subunit vaccine demonstrates potential for inducing immunogenic responses and memory cell formation.
• This vaccine candidate may offer protection against HCMV-mediated diseases and associated complications.
• Further research and development could lead to a viable vaccine against HCMV.